2 Top Diabetes Stocks to Buy in May

Diabetes is a severe chronic health condition that affects about 34.2 million people in the U.S. alone, which represents approximately 10% of the country's population. Many more people -- an estimated one in three Americans -- are at risk of developing diabetes.

Fortunately, many companies develop products, like drugs and insulin pumps, that help meet the needs of diabetics. Tandem Diabetes Care (NASDAQ: TNDM) and Eli Lilly (NYSE: LLY) are two such companies. Here's why both of these healthcare stocks are worth buying, even given today's highly uncertain economic conditions.